Home    中文  
 
  • Search
  • lucene Search
  • Citation
  • Fig/Tab
  • Adv Search
Just Accepted  |  Current Issue  |  Archive  |  Featured Articles  |  Most Read  |  Most Download  |  Most Cited

Chinese Journal of Experimental and Clinical Infectious Diseases(Electronic Edition) ›› 2016, Vol. 10 ›› Issue (01): 106-111. doi: 10.3877/cma.j.issn.1674-1358.2016.01.026

• Clinical Research Article • Previous Articles     Next Articles

Distribution and resistance of nosocomial infection pathogen from a new private general hospital

Yuhua Liao1,(), Lei Yang1, Peizhang He2, Haitao Ren1, Zhenzhen Liu1, Hongdao Wang3   

  1. 1. Intensive Care Unit, Henan Honliv Hospital, Changyuan, 453400 China
    2. Department of Clinical Laboratory, Henan Honliv Hospital, Changyuan, 453400 China
    3. Department of Infection Control, Henan Honliv Hospital, Changyuan, 453400 China
  • Received:2015-03-17 Online:2016-02-15 Published:2021-09-08
  • Contact: Yuhua Liao

Abstract:

Objective

To investigate the distribution and antibacterial resistance of nosocomial infection pathogens from a new private general hospital, and to provide reference for clinical rational use of antibacterial agents.

Methods

The data of pathogens formation, distribution and antibacterial resistance of a new general private hospital from January 1st 2008 to December 30th 2011, which included 3 728 strains were analyzed by χ2 test, making a comparison with CHINET 2010 surveillance of bacterial resisitance in China and the new grade-three hospital.

Results

Among all the strains, Gram-negative bacteria and Gram-positive bacteria accounted for 79.8% and 20.2%, respectively, of which Escherichia coli, Pseudomonas aeruginosa, Klebsiella, Acinetobacter, Staphylococcus aureus and coagulase-negative Staphyococcus were common in the Gram-negative bacteria, and Klebsiella were highly sensitive to cefoperazone-sulbactam, imipenem and meropenem, with the resistant rate of 0%, significantly lower than those of CHINET 2010 in China, with significant differences (P all < 0.01). The resistance rates of Escherichia coli to the three drugs were 1.52%, 1.2% and 1.39%, lower than those of the CHINET results, and the resistance rates to cefoperazone-sulbactam were with significant differences (P all < 0.01), and the resistant rates to imipenem and meropenem were not significantly different (P = 0.315 and 0.988). The resistance rates of Pseudomonas aeruginosa to the above three drugs were 16.96%, 22.84% and 29.3%, while the resistance rate to cefoperazone-sulbactam was not significantly different (P = 0.536), the resistance rate to imipenem and meropenem were significantly different (P < 0.01 and < 0.05). The resistance rates of Acinetobacter to the three drugs were 4.5%, 47.5% and 39.9%, significantly lower than those of CHINET results (P all < 0.01). Gram-positive cocci to vancomycin, teicoplanin and linezolid were highly sensitive, with the resistance rates of 0%, which was same to the CHINET results. Compared with the drug resistance rates of the West District of Beijing Chaoyang Hospital, the resistance rates of Pseudomons asaeruginosa to gentamicin, piperacillin-tazobactam and meropenem were 67.45%, 36.69% and 29.3%, which were significantly higher than those of the West District of Beijing Chaoyang Hospital (P all < 0.01). The resistance rates of Escherichia coli were similar in the two hospital, with no significant differences (P > 0.05). Compared with the resistance rate of Gram-positive cocci in the West District of Beijing Chaoyang Hospital, and Staphyococcus resistance rate was significantly lower (P all < 0.01).

Conclusions

Formation, distribution and antibacterial resistance of the new general private hospital’s nosocomial infection pathogens were consistent with the domestic related research results.

Key words: New private hospital, Nosocomial infection, Pathogen, Drug resistance

京ICP 备07035254号-20
Copyright © Chinese Journal of Experimental and Clinical Infectious Diseases(Electronic Edition), All Rights Reserved.
Tel: 010-85322058 E-mail: editordt@163.com
Powered by Beijing Magtech Co. Ltd